The average one-year price target for WW International (NasdaqGM:WW) has been revised to $49.98 / share. This is an increase ...

WW International press release (NASDAQ:WW): Q4 EPS of -$1.11 may not be comparable to consensus of -$0.09. Revenue of $206M (-7.6% Y/Y) misses by $0.91M. End of Period Subscribers of 3.8 million, ...

WW stock popped 38% on October 9 with the company revealing a new compounded semaglutide product to benefit from the current shortage of weight loss drugs in the market. The company has already ...

Sept. 28 (UPI) --WW International has removed CEO Sima Sistani from the chief executive role effective immediately, the company previously known as Weight Watchers said in a statement. Sistani leaves ...

WW reported quarterly losses of 13 cents per share, missing the Street estimate of earnings of 1 cent. Quarterly sales also came in below estimates at $202.1 million. WW ended the period with 3.8 ...

Kingdom Capital Advisors, a private investment firm, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the third quarter, the portfolio recovered from ...

WW International, Inc. WW stock has shown a remarkable performance in the past three months, outpacing the S&P 500 and the industry. In the same time frame, WW has surged 66.8% compared with the ...

WeightWatchers' CEO of roughly two years, Sima Sistani, is out. She helped push the company into the white-hot weight-loss drug space. Its interim chief said the company was in a critical period of ...

Ozempic Patent Expires In Canada After Novo Nordisk Fails To Pay $450 Fee: 'It's The Second-Largest Semaglutide Market In The World,' Says Sandoz CEO Richard Saynor (UPDATED) A simple oversight could ...

A prognosticator sounded a warning about the weight loss specialist. He noted that competition is increasing, and traditional dieting methods are declining in popularity. The analyst in question was ...